ethylisopropylamiloride has been researched along with Colorectal Cancer in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serafino, A | 1 |
| Moroni, N | 1 |
| Psaila, R | 1 |
| Zonfrillo, M | 1 |
| Andreola, F | 1 |
| Wannenes, F | 1 |
| Mercuri, L | 1 |
| Rasi, G | 1 |
| Pierimarchi, P | 1 |
1 other study available for ethylisopropylamiloride and Colorectal Cancer
| Article | Year |
|---|---|
Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
Topics: Adenocarcinoma; Amiloride; Animals; Atrial Natriuretic Factor; beta Catenin; Breast Neoplasms; Cell | 2012 |